Early Catheter Removal for Urogynecologic Surgery
(CARES2 Trial)
Trial Summary
What is the purpose of this trial?
Management of postoperative urinary retention often requires the use of indwelling catheters. In a previous study, the investigators determined that patient removal of catheters at home is non-inferior to standard office removal on postoperative day three or four (POD3-4). The purpose of this study is to determine whether patient removal of catheters at home on postoperative day one (POD1) is noninferior to removal on POD 3-4.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Early catheter removal for Urogynecologic Surgery?
Research shows that early removal of urinary catheters can reduce urinary tract infections and improve recovery after surgery. For example, studies found that early catheter removal after cesarean delivery and rectal cancer surgery led to fewer urinary symptoms and infections, suggesting similar benefits could apply to urogynecologic surgery.12345
Is early catheter removal safe for patients after urogynecologic surgery?
How does early catheter removal differ from other treatments for urogynecologic surgery?
Early catheter removal is unique because it involves taking out the urinary catheter soon after surgery, which can help reduce the risk of urinary tract infections and speed up recovery. This approach contrasts with traditional methods that often leave the catheter in place for a longer period.12358
Research Team
Lauren Tholemeier, MD
Principal Investigator
University of North Carollina at Chapel Hill
Eligibility Criteria
This trial is for women who have had prolapse or anti-incontinence surgery and can't empty their bladder properly before leaving the hospital. It's not for those who don't speak English, are pregnant, needed catheterization before surgery, got urethral injections, or had complications during surgery needing longer catheter use.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment/Intervention
Participants undergo urogynecologic surgery and are randomized to catheter removal on POD1 or POD3-4
Postoperative Monitoring
Participants are monitored for voiding symptoms and complications, with a phone call at week 2 and an office visit at week 6
Follow-up
Participants are monitored for postoperative complications such as UTI or urinary retention
Treatment Details
Interventions
- Early catheter removal
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor